The three systems: A conceptual way of understanding nocturnal enuresis

Scandinavian Journal of Urology and Nephrology

Volumn 34, Issue 4, 2000, Pages 270-277

  Butler, R J ^a   Holland, P ^a  

^a High Royds Hospital   (United Kingdom)

Author keywords

Arousability; Bladder instability; Nocturnal enuresis; Three systems model; Treatment; Vasopressin

Indexed keywords

ARGIPRESSIN;

AROUSAL; ARTICLE; BLADDER INSTABILITY; CONCEPT FORMATION; COPING BEHAVIOR; HELPLESSNESS; HUMAN; MONITORING; NOCTURNAL ENURESIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SELF ESTEEM; VASOPRESSIN RELEASE;

AROUSAL; CHILD; ENURESIS; HUMANS; SLEEP DISORDERS; URINARY BLADDER; VASOPRESSINS;

EID: 0034519662     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655900750042022     Document Type: Article

References (86)

1. Nocturnal enuresis: The child's experience
2. Self esteem before and after treatment in children with nocturnal enuresis and urinary incontinence
3. Association of common health symptoms with bullying in primary school children
4. Improvements in self-concept after treatment of nocturnal enuresis: Randomised controlled trial
5. Nocturnal enuresis and behaviour problems in adolescence: A 15 year longitudinal study
6. Clinical enuresis phenotypes in familial nocturnal enuresis
7. Childhood nocturnal enuresis: The prediction of premature withdrawal from behavioural conditioning
8. Enuresis in seven year old children
9. Maternal attributions and tolerance for nocturnal enuresis
10. The maternal tolerance scale and nocturnal enuresis
11. Fifty years of enuresis alarms
12. The prevalence of nocturnal enuresis: Do DSM-III criteria need to be changed?
13. A 6 year follow up of childhood enuresis: Prevalence in adolescence and consequences for mental health
14. Subtypes in monosymptomatic nocturnal enuresis
15. Nocturnal enuresis: A suggestion for a European treatment strategy
16. Definitions of subtypes of enuresis
17. Annotation: Night wetting in children: Psychological aspects
18. Treatment systems for nocturnal enuresis according to an original classification system
19. Physiological background of enuresis Type I: A preliminary report
20. Sleep patterns in children with nocturnal enuresis
21. Is small bladder capacity a cause of enuresis?
22. Sleep disturbance and bladder dysfunction in enuretic children with treatment failure: Fact or fiction?
23. A pharmacodynamic study of desmopressin in patients with nocturnal enuresis
24. Differential diagnosis for nocturnal enuresis
25. Pulsatile release of arginine vasopressin (AVP) and its effect on response to desmopressin in enuresis
26. Plasma vasopressin and response to treatment in primary nocturnal enuresis
27. Voiding frequency, volumes and intervals in healthy schoolchildren
28. Diurnal antidiuretic hormone levels in enuretics
29. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis
30. Monosymptomatic primary enuresis: Differences between patients responding or not responding to oral desmopressin
31. Desmopressin in the treatment of severe nocturnal enuresis - A 7 year follow up study
32. Sleep arousal function in enuretic males
33. The epidemiology of childhood enuresis in Australia
34. Children's notions about enuresis and the implications for treatment
35. Childhood enuresis 1: Sleep patterns and psychopathology
36. Nocturnal enuresis: An approach to treatment based on pathogenesis
37. The pathophysiology of enuresis in children and young adults
38. Primary sleep enuresis in childhood: Polysomnographic evidence of sleep stage and time modulation
39. The child's construing of nocturnal enuresis: A method of inquiry and prediction of outcome
40. Parental perceptions of enuresis: A collaborative study
41. Parental attitudes and the conditioning treatment of childhood enuresis
42. A controlled comparison of two treatments for nocturnal enuresis
43. A comparison of two approaches to the treatment of nocturnal enuresis and the prediction of effectiveness using pre-treatment variables
44. Effectiveness of oxybutyninhydrochloride in the treatment of enuresis nocturna
45. A possible explanation of wet and dry nights in enuretic children
46. Management of nocturnal enuresis with a vasopressin analogue
47. Comparison of intranasal and oral desmopressin for nocturnal enuresis
48. Comparison of desmopressin and enuresis alarm for nocturnal enuresis
49. Oral desmopressin as a new treatment for primary nocturnal enuresis in adolescents and adults: A double-blind, randomised, multi-centre study
50. Desmopressin acetate and nocturnal enuresis: How much do we know?
51. Primary nocturnal enuresis: A comparison among observation, imipramine, desmopressin acetate and bed-wetting alarm systems
52. Nocturnal enuresis and daytime wetting: A multicentre trial with oxybutynin and desmopressin
53. Hypnotherapy as a treatment for enuresis
54. Establishing a dry run: A case study in securing bladder control
55. Arousal training for children suffering from nocturnal enuresis: A 2-year follow up
56. A component analysis of dry bed training for treatment of bedwetting
57. Dry-bed-training: Rapid elimination of childhood enuresis
58. Treatment of nocturnal enuresis with the bell and pad system
59. Nocturnal enuresis as a biobehavioural problem
60. Behavioural treatments for nocturnal enuresis in children: A review of the recent literature
61. Enuresis
62. Long term use and tapered dose reduction of intranasal desmopressin in the treatment of 155 enuretic children
63. Combination therapy in the treatment of persistent nocturnal enuresis
64. Evaluation of antidiuretic hormone, before and after long term treatment with desmopressin in a group of enuretic children
65. Desmopressin response of enuretic children: Effects of age and frequency of enuresis
66. Predictors of response to desmopressin in children and adolescents with monosymptomatic nocturnal enuresis
67. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis
68. Desamino-D-vasopressin in childhood nocturnal enuresis
69. The effectiveness of desmopressin in the treatment of childhood nocturnal enuresis: Predicting response using pre-treatment variables
70. Micturition habits and bladder capacity in normal children and in patients with desmopressin resistant enuresis
71. Osmoregulation and desmopressin pharmacokinetics in enuretic children
72. Genetic factors as predictors for desmopressin treatment success
73. Desmopressin in nocturnal enuresis
74. Long term home studies of water balance in patients with nocturnal enuresis
75. Early disturbing events and later enuresis
76. Reasons for appointment failure among enuretic patients
77. Predicting treatment outcome with conditioning alarms
78. Effectiveness of psychological and pharmacological treatments for nocturnal enuresis
79. Factors associated with drop out, relapse and failure in the conditioning treatment of nocturnal enuresis
80. Life changes and protective capacities in enuretic and non-enuretic children
81. Childhood nocturnal enuresis: Factors associated with outcome of treatment with an enuresis alarm
82. Predicting treatment outcome in nocturnal enuresis
83. Relapse and therapeutic response in the conditioning treatment of enuresis
84. Drug therapy for nocturnal enuresis: Current treatment recommendations
85. Preventing relapse following medication for the treatment of childhood nocturnal enuresis
86. Development of melatonin production in infants and the impact of prematurity